Gala vs WeightWatchers (Sequence): Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
WeightWatchers (Sequence) beats Gala overall, scoring 7.4/10 vs 7/10. WeightWatchers (Sequence) is more affordable at $74/mo vs $149/mo. Choose Gala for users who want low-cost compounded tirzepatide and a built-i. Choose WeightWatchers (Sequence) for users who want glp-1 medication combined with the weightwatc.
A side-by-side comparison of Gala and WeightWatchers (Sequence) covering pricing, scores, medication types, insurance, and more to help you decide.
Gala
#40 of 42Telehealth platform offering compounded semaglutide and tirzepatide at competitive pricing, plus a paid path to brand semaglutide. Differentiator: a dedicated iOS GLP-1 tracker app for users who want to log dosing, weight, and side effects in one place.
Visit GalaWeightWatchers (Sequence)
#26 of 42WeightWatchers' clinical weight management arm (acquired from Sequence) restructured in 2026: $74/mo ongoing membership (first 2 months $25 intro) + medication billed separately. Intro medication pricing $199/mo first 2 months, $349/mo ongoing. Added Saxenda (liraglutide) to the lineup.
Visit WeightWatchers (Sequence)| Feature | Gala | WeightWatchers (Sequence) |
|---|---|---|
| Our Score | 7/10 | 7.4/10 |
| Starting Price | $149/mo | $74/mo |
| Medication Type | Both | Both |
| Insurance Accepted | No | Yes |
| Best For | Users who want low-cost compounded tirzepatide and a built-in iOS tracker app for daily progress logging | Users who want GLP-1 medication combined with the WeightWatchers program and community — restructured 2026 with decoupled membership + medication pricing |
| Ranking | #40 | #26 |
Pros & Cons Compared
Gala
Pros
- +Compounded tirzepatide as low as $149/mo on the longest commitment plan — among the cheapest tirz options on the market
- +$199/mo entry pricing on a 3-month plan for compounded semaglutide — competitive in the mid-tier
- +Dedicated 'Gala GLP-1 Tracker' iOS app for dosing, weight, and side-effect logging — uncommon among compounded-only platforms
- +Both semaglutide and tirzepatide available, plus a brand-name semaglutide path for users who specifically want FDA-approved
Cons
- −Brand-name semaglutide pricing ($1,299/mo) is significantly above market — NovoCare direct pricing for Wegovy is $349/mo
- −Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness
- −Newer brand (Delaware-registered, limited public company history) — less track record than established platforms like Henry Meds or Sprout
- −No published lab panels or specialty clinical oversight — state-licensed prescriber review is the standard, not differentiated
WeightWatchers (Sequence)
Pros
- +Combines GLP-1 medication with WeightWatchers' proven points system and community support
- +Insurance accepted for medication — can reduce costs significantly with qualifying plans
- +Decades of brand trust and weight loss expertise applied to clinical medication management
- +Access to WW community, workshops, and digital tools alongside medication
Cons
- −$269/mo without insurance is expensive for what's included clinically
- −The WW program integration adds complexity that medication-only users won't value
- −The Sequence acquisition is still integrating — some operational inconsistencies remain
- −Less medication flexibility than pure-play GLP-1 platforms
Our Verdict
WeightWatchers (Sequence) edges out Gala with a score of 7.4/10 vs 7/10. If budget is your priority, WeightWatchers (Sequence) starts at $74/mo compared to Gala's $149/mo. WeightWatchers (Sequence) accepts insurance, which can significantly reduce your out-of-pocket costs. Choose Gala if you want: users who want low-cost compounded tirzepatide and a built-in ios tracker app for daily progress logging. Choose WeightWatchers (Sequence) if you want: users who want glp-1 medication combined with the weightwatchers program and community — restructured 2026 with decoupled membership + medication pricing.